SiranBio: Funding, Investors & Team (Sep 2026)
SiranBio is a biotechnology that develops innovative siRNA drugs.
SiranBio has raised $59.5M across 1 funding round on record, the most recent a Series A of $59.5M announced in Aug 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
SiranBio Company Profile and Key Stats
Latest funding round on record: Aug 2026.
SiranBio Funding Rounds
SiranBio Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
SiranBio Funding in Context
SiranBio's latest round of $59.5M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SiranBio in Biopharma and Suzhou
Companies Similar to SiranBio
Ubot Robotics is dedicated to developing leg-and-foot bionic robots.
Mogulinker Technology is a domestic SaaS software provider specializing in the post industrial equipment…
Medefa is a startup that uses cutting-edge synthetic biology engineering technologies to mass-produce novel…
VAST develops generative AI technologies for 3D content creation and virtual world-building.
Violoop develops AI hardware and software that enables computers to perform tasks across applications using…
Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical…
Haofeng Medtech is a CDMO service provider of interventional medical devices.
Nova Fusion is a nuclear fusion energy company that develops small modular reactors for distributed power…
Convergen develops targeted protein degradation therapies for diseases associated with pathological protein…
Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule…
Miwei Technology is a space-based intelligent computing service provider.
Lingchu is an embodied intelligence startup company that specializes in robot skill set training using…
SiranBio Funding FAQs
What does SiranBio do?
SiranBio is a biotechnology that develops innovative siRNA drugs.
How much funding has SiranBio raised?
SiranBio has raised $59.5M across 1 round on record. The most recent is a Series A of $59.5M announced in Aug 2026.
When did SiranBio last raise funding?
SiranBio's most recent funding round on record is a Series A of $59.5M, announced in Aug 2026.
Who has invested in SiranBio?
Investors on record for SiranBio include Suzhou Haoping, IDG Capital, RiverHead Capital, BioVenture, Huatai Zijin Investment. FundedIQ records 10 investors in total.
Where is SiranBio headquartered?
SiranBio is based in Suzhou, China.
When was SiranBio founded?
SiranBio was founded in 2022.
About FundedIQ's SiranBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SiranBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.